"U.S. Supply Chain Security at Risk: Counterfeit and Foreign Unapproved Drugs Pose a Significant Public Health Threat to the American Public," Congressional Briefing, March 16, 2017
•Download as PPTX, PDF•
0 likes•87 views
A presentation by George Karavetsos, DLA Piper, former director of FDA’s Office of Criminal Investigations.
Recommended
Recommended
More Related Content
More from The Partnership For Safe Medicines
More from The Partnership For Safe Medicines (20)
Recently uploaded
Recently uploaded (20)
"U.S. Supply Chain Security at Risk: Counterfeit and Foreign Unapproved Drugs Pose a Significant Public Health Threat to the American Public," Congressional Briefing, March 16, 2017
- 1. www.dlapiper.com 1Insert date with ‘Firm Tools > Change Presentation’ U.S. PHARMACEUTICAL SUPPLY CHAIN SECURITY AT RISK: COUNTERFEIT AND FOREIGN UNAPPROVED DRUGS POSE A SIGNIFICANT PUBLIC HEALTH THREAT TO THE AMERICAN PUBLIC The Partnership for Safe Medicines Congressional Briefing March 17, 2017 George M. Karavetsos DLA Piper LLP (US) 200 South Biscayne Boulevard, Suite 2500 Miami, FL 33131 (305) 423-8510 George.Karavetsos@dlapiper.com
- 2. Foreign Unapproved Drugs are not coming from Canada 2
- 3. The Public Health Threat is Real Sophisticated Criminal Organizations were Profiting at the Expense of the Public’s Health ●TC Medical ●Gallant Pharma ●Medical Device King ●Canada Drugs 3
- 6. 6 Path of Counterfeit Drugs 6
- 7. FDA Warning Notifications Sent to Doctors and Clinics 7
- 8. The Harm is Real Late stage lung cancer Betty Hunter was treated with counterfeit Avastin in 2011. Ms. Hunter died three months later. 8
- 9. 99